Since 2013, Cure Alzheimer’s Fund has been supporting research by the distinguished neuroscientist and Down syndrome (DS) expert William Mobley, M.D., Ph.D., whose lab is based at the University of California, San Diego. Mobley is part of a team working to exploit a hypothesis that inhibiting a protein called monoacylglycerol lipase (MAGL)—which gets overproduced in people with Down syndrome—will, in turn, reduce the production of Abeta and, subsequently, Alzheimer’s neuropathology.
Join us for a conversation with Dr. Mobley on his research into Down syndrome and Alzheimer's. Mobley will discuss his work and explain how further understanding the connection between DS and AD may benefit people with both conditions.
There is no need to register for the webinar—simply return to this page (http://curealz.org/webinar) on September 3 to join.